Evidence map›Paper›PMID 39312180›Full record

ArticleThe Biochemical journal2024

Yop1 stability and membrane curvature generation propensity are controlled by its oligomerisation interface.

Anu V Chandran, Daniel Álvarez, Stefano Vanni, Jason R Schnell

Abstract read
In one paragraph

Article in The Biochemical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anu V ChandranDepartment of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, U.K.
Daniel ÁlvarezDepartment of Biology, University of Fribourg, Fribourg, Switzerland.
Stefano VanniDepartment of Biology, University of Fribourg, Fribourg, Switzerland.
Jason R SchnellDepartment of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, U.K.ORCID 0000-0002-8204-7608

Funding

Medical Research Council M019152
6 · The paper itself

Abstract

The DP1 family of integral membrane proteins stabilize high membrane curvature in the endoplasmic reticulum and phagophores. Mutations in the human DP1 gene REEP1 are associated with Hereditary Spastic Paraplegia type 31 and distal hereditary motor neuropathy. Four missense mutations map to a putative dimerization interface but the impact of these mutations on DP1 structure and tubule formation are unknown. Combining biophysical measurements, functional assays, and computational modeling in the context of the model protein Yop1, we found that missense mutations have variable effects on DP1 dimer structure and in vitro tubulation activity, and provide mechanistic insights into the role of DP1 oligomerisation on membrane curvature stabilization. Whereas the mutations P71L and S75F decreased dimer homogeneity and led to polydisperse oligomerization and impaired membrane curving activity, A72E introduced new polar interactions between subunits that stabilized the Yop1 dimer and allowed robust tubule formation but prevented formation of more highly-curved lipoprotein particles (LPP). The introduction of a BRIL domain to the cytoplasmic loop of A72E rescued LPP formation, consistent with a requirement for dimer splaying in highly curved membranes. These results suggest that the membrane curving activity of DP1 proteins requires both dimer stability and conformational plasticity at the intermolecular interface.

Indexed as

Membrane Transport ProteinsMutation, MissenseCell MembraneEndoplasmic ReticulumHumansProtein MultimerizationProtein StabilityMembrane Transport ProteinsDP1hereditary spastic paraplegiamembranesreticulon homology domainYop1

Identifiers

PMID39312180
PMCPMC11555649

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.